Live

Endpoints NewsFDA delays Leqembi decision; Artiva raises $300M; Pharvaris prices offering CellFronto-insular circuit mechanisms of accelerated intermittent theta burst stimulation CellA blood-brain barrier-like vascular gate limits immunotherapy efficacy in neuroendocrine cancers CellA cell type-specific mechanism driving the rapid antidepressant effects of transcranial magnetic stimulation FierceBiotechAnalysts cut enGene cancer sales forecast after updated data widen gap to J&J BioPharma DiveFDA to reevaluate spurned cell therapy; Under-the-skin Leqembi review extended 10x Genomics News10x Genomics Q1 Earnings & Revenues Beat Estimates, Gross Margin Up - Zacks Investment Research Eli LillyWill Eli Lilly Be the First $2 Trillion Healthcare Stock? 3 Catalysts That Could Get It There. - The Motley Fool AbbottAbbott's Medical Device Strategy Supports Long-Term Growth Outlook - The Globe and Mail FDA News ReleasesFDA Issues Guidance to Improve Collection of Pregnancy Safety Data for Drugs and Biologics BioPharma DiveLilly, Gilead lead pharma’s M&A boom Endpoints News'Pharma, not really’: Top young AI talent shuns careers at big drugmakers

Cell May 8, 2026

A blood-brain barrier-like vascular gate limits immunotherapy efficacy in neuroendocrine cancers

Publication date: Available online 7 May 2026 Source: Cell Author(s): Yiyun Wang, Ailing Zhong, Bo Wang, Xiaoqian Zhai, Chang Lei, Zuoyu Liang, Xintong Deng, Ji...

Publication date: Available online 7 May 2026 Source: Cell Author(s): Yiyun Wang, Ailing Zhong, Bo Wang, Xiaoqian Zhai, Chang Lei, Zuoyu Liang, Xintong Deng, Jian Zhong, Chaoxin Xiao, Jianan Zheng, Baohong Wu, Lanxin Zhang, Yuying Wang, Xiangmeng Luo, Jian Wang, Mengsha Zhang, Hongyu Liu, Xudong Wan, Siqi Dai, Yucen Yang